StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.71+0.10 (+0.26%)

Close on Nov 17, 2026Market cap $27.96BP/E –Yield –

Roivant Sciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Roivant Sciences's pe ratio was 2.0× on Jan 31, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20252.0×−0.1
2024Dec 31, 20242.1×–

More Roivant Sciences figures

See a number that looks wrong?